We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

101 hedge funds and large institutions have $20.5M invested in Definium Therapeutics in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more call options, than puts

Call options by funds: $20.9M | Put options by funds: $6.14M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

37% more capital invested

Capital invested by funds: $14.9M → $20.5M (+$5.59M)

19.01% more ownership

Funds ownership: 0.36% → 19.37% (+19%)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

35% less funds holding

Funds holding: 155 → 101 (-54)

75% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 72

Holders
101
Holders Change
-54
Holders Change %
-34.84%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
18
Increased
34
Reduced
34
Closed
72
Calls
$20.9M
Puts
$6.14M
Net Calls
+$14.7M
Net Calls Change
+$13.7M

Top Buyers

1
DCI
Data Collective IV
California
+$13.5M
2
MFG
Merit Financial Group
Georgia
+$10M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$9.6M
4
CH
CVI Holdings
Delaware
+$6.26M
5
EAM
Empery Asset Management
New York
+$1.8M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$1.76M
2
E
Ergoteles
New York
-$696K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$405K
4
LPL Financial
LPL Financial
California
-$324K
5
PCM
Penserra Capital Management
California
-$282K
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
101
Cutler Group
California
– -$12.7K -1,319 -94%
RFC
102
Regions Financial Corp
Alabama
– -$12K -1,267 Closed
CIBC World Market
103
CIBC World Market
Ontario, Canada
– -$11.7K -1,215 Closed
RJA
104
Raymond James & Associates
Florida
– -$12K -1,206 Closed
Two Sigma Advisers
105
Two Sigma Advisers
New York
– -$11K -1,100 Closed
Invesco
106
Invesco
Georgia
– -$10K -1,040 Closed
V
107
Veritable
Delaware
– -$10K -1,007 Closed
FBB
108
Fulton Breakefield Broenniman
Maryland
– -$10K -1,000 Closed
FAIM
109
Financial Advocates Investment Management
Washington
– -$9K -969 Closed
DIM
110
Delta Investment Management
California
– -$9K -951 Closed
VFA
111
Valeo Financial Advisors
Indiana
– -$9K -935 Closed
EWM
112
Endowment Wealth Management
Wisconsin
– -$9K -928 Closed
NSIM
113
North Star Investment Management
Illinois
– -$8.71K -907 -96%
OC
114
Oppenheimer & Co
New York
– -$8K -854 Closed
RCA
115
Ranch Capital Advisors
Florida
– -$8K -840 Closed
CAPTRUST Financial Advisors
116
CAPTRUST Financial Advisors
North Carolina
– -$8K -837 Closed
VAG
117
VisionPoint Advisory Group
Texas
– -$8K -833 Closed
SS
118
Simplicity Solutions
Minnesota
– -$8K -821 Closed
WWM
119
Western Wealth Management
Colorado
– -$8K -800 Closed
Fidelity Investments
120
Fidelity Investments
Massachusetts
– -$7.61K -793 -98%
UCFA
121
United Capital Financial Advisors
Texas
– -$7K -775 Closed
AWM
122
Apollon Wealth Management
South Carolina
– -$7K -762 Closed
AFP
123
Ausdal Financial Partners
Iowa
– -$7K -738 Closed
NP
124
NorthRock Partners
Minnesota
– -$7K -713 Closed
TSS
125
Two Sigma Securities
New York
– -$7K -709 Closed
3 4
5
6 7

DFTX Hedge Fund Activity: Q3 2022 in Review

101 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2022, worth a combined $20.5M — up 37% from $14.9M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of DFTX and 18 opened new positions — a net loss of 54 holders — while 34 trimmed existing stakes and 34 added.

The largest buyer was Data Collective IV, adding an estimated $13.5M. The largest seller was Millennium Management, cutting an estimated $1.76M.

  • 101 institutional investors held Definium Therapeutics (DFTX) as of Q3 2022, down from 155 in Q2 2022.
  • Funds reported $20.5M of Definium Therapeutics stock for Q3 2022, up 37% quarter-over-quarter.
  • 18 funds opened new Definium Therapeutics positions in Q3 2022 and 72 closed out, a net change of -54 holders.
  • The largest Definium Therapeutics buyer in Q3 2022 was Data Collective IV, an estimated $13.5M added.
  • The largest Definium Therapeutics seller in Q3 2022 was Millennium Management, an estimated $1.76M sold.

Based on aggregated 13F filings for Q3 2022.